Hirmerova Jana, Liska Vaclav, Mirka Hynek, Chudacek Zdenek, Treska Vladislav
2nd Department of Internal Medicine, University Hospital, Charles University, Pilsen-Bory, Dr. E. Benese 13, Pilsen, Czech Republic.
Clin Appl Thromb Hemost. 2008 Oct;14(4):481-5. doi: 10.1177/1076029607308392. Epub 2007 Dec 26.
A 65-year-old man was examined for abdominal pain. Portal and mesenteric vein thromboses were described by ultrasound and computed tomography. No local cause was found. The patient had a positive history of venous thromboembolism. Thrombophilia workup revealed prothrombin G20210A mutation (heterozygous), C677T mutation of methylenetetrahydrofolate reductase gene (homozygous), elevated level of lipoprotein (a), and high level of coagulation factor VIII. Anticoagulation was started and planned for a long-term duration. The etiology of portal vein thrombosis is often multifactorial, with various combinations of systemic factors (inherited or acquired prothrombotic conditions) and local precipitating factors (inflammation, injury to the portal venous system, cancer of the abdominal organs, cirrhosis). The reported prevalence of hypercoagulable states in patients with portal vein thrombosis has been very heterogeneous so far. Some authors support a role of the prothrombin G20210A mutation. In the reported patient, this mutation was revealed in a combination with other hypercoagulable states.
一名65岁男性因腹痛接受检查。超声和计算机断层扫描显示门静脉和肠系膜静脉血栓形成。未发现局部病因。该患者有静脉血栓栓塞的阳性病史。血栓形成倾向检查发现凝血酶原G20210A突变(杂合子)、亚甲基四氢叶酸还原酶基因C677T突变(纯合子)、脂蛋白(a)水平升高以及凝血因子VIII水平升高。开始抗凝治疗并计划长期进行。门静脉血栓形成的病因通常是多因素的,包括全身因素(遗传性或获得性血栓前状态)和局部促发因素(炎症、门静脉系统损伤、腹部器官癌症、肝硬化)的各种组合。迄今为止,门静脉血栓形成患者中高凝状态的报告患病率差异很大。一些作者支持凝血酶原G20210A突变的作用。在该报告的患者中,该突变与其他高凝状态同时出现。